Advertisements



Here"s Why Sarepta Therapeutics Jumped 17% in September

Lifting of a clinical hold continued the momentum......»»

Category: topSource: foxnewsOct 11th, 2018

Here"s Why Global Blood Therapeutics Fell 10.1% in November, Then Jumped 37% Since

The company reported boring third-quarter 2018 operating results, but followed up with important clinical updates in the first week of December......»»

Category: topSource: foxnewsDec 11th, 2018

Is Sarepta Therapeutics Inc (SRPT) A Good Stock To Buy?

Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dolla.....»»

Category: topSource: insidermonkeyDec 8th, 2018

Why Arena Pharma Is Winning Big With Its New Collaboration

Arena Pharmaceuticals shares jumped early on Thursday after the company announced a new global license agreement with United Therapeutics......»»

Category: blogSource: 247wallstNov 15th, 2018

Sands Capital Management Buys Sarepta Therapeutics Inc, Edwards Lifesciences Corp, Abiomed Inc, ...

Related Stocks: EW, GLPG, FND, HDB, ZTS, SRPT, ABMD, HCM, BGNE, EB, BAP, CSCO,.....»»

Category: smallbizSource: nytNov 14th, 2018

Corcept Therapeutics (CORT) Meets Q3 Earnings Estimates

Corcept (CORT) delivered earnings and revenue surprises of 0.00% and -4.10%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?.....»»

Category: worldSource: nytNov 1st, 2018

Fate Therapeutics (FATE) Reports Q3 Loss, Lags Revenue Estimates

Fate Therapeutics (FATE) delivered earnings and revenue surprises of -29.17% and -72.98%, respectively, for the quarter ended September 2018.....»»

Category: personnelSource: nytNov 1st, 2018

Sarepta Therapeutics Inc (SRPT) President & CEO Douglas S Ingram Bought $2 million of Shares

Related Stocks: SRPT,.....»»

Category: dealsSource: nytOct 30th, 2018

Sarepta, Lysogene Announce Exclusive License Agreement for LYS - SAF302, a Late- stage Gene Therapy for the Treatment of MPS IIIA; Grant of Option Rights to an Additional CNS Gene Therapy Candidate

Sarepta Therapeutics, Inc. read more.....»»

Category: blogSource: benzingaOct 26th, 2018

Sarepta (SRPT) Q3 Earnings & Sales Miss, Exondys 51 Sales Up

Sarepta (SRPT) misses estimates on both counts in third-quarter 2018. However, Exondys 51 performs well on strong demand. Sarepta Therapeutics, Inc. SRPT incurred an adjusted loss of 56 c.....»»

Category: smallbizSource: nytOct 25th, 2018

Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q3 2018 Results - Earnings Call Transcript

Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaOct 25th, 2018

Sarepta Therapeutics, Inc. 2018 Q3 - Results - Earnings Call Slides

Sarepta Therapeutics, Inc. 2018 Q3 - Results - Earnings Call Slides.....»»

Category: topSource: seekingalphaOct 24th, 2018

Sarepta had $793.9M in cash, equivalents as of September 30

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 24th, 2018

Q3 Earnings Preview For Sarepta Therapeutics

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) announces its next round of earnings this Wednesday, Oct. 24. Here's Benzinga's advanced look at Sarepta's Q3 earnings report. read more.....»»

Category: blogSource: benzingaOct 24th, 2018

Here"s Why CRISPR Therapeutics Has Lost One-Third of Its Value Since September

A share offering didn't help. Investors also began to wonder: Was a $2.5 billion market cap justified?.....»»

Category: topSource: foxnewsOct 11th, 2018

Here"s Why Shares of Ballard Power Systems Inc. Jumped 21% in September

The company's decision to lower its involvement in the defense industry and the announcement of a new fuel cell powered the gains......»»

Category: topSource: foxnewsOct 11th, 2018

Here"s Why Viking Therapeutics Skyrocketed 33% in September

Solid phase 2 data has investors excited about the biotech's future......»»

Category: topSource: foxnewsOct 11th, 2018

Why Abiomed Stock Jumped 10.6% in September -- and Is Down 16.6% in October

Despite the recent sell-off, shares of this high-flying heart pump maker are up 100% in 2018......»»

Category: topSource: foxnewsOct 11th, 2018

Why MongoDB, Inc. Stock Jumped 13.3% in September

The database platform leader delivered another quarterly beat last month. Here's what investors need to know......»»

Category: topSource: foxnewsOct 10th, 2018

Hedge Fund and Insider Trading News: Bill Ackman, Trian Fund Management, Paul Singer, vTv Therapeutics Inc (VTVT), BioDelivery Sciences International, Inc. (BDSI), CarGurus Inc (CARG), and More

Starbucks Spikes After Hedge-Fund Billionaire Bill Ackman Discloses a Stake in the Company (Business Insider) Starbucks shares jumped by a.....»»

Category: topSource: insidermonkeyOct 10th, 2018

Egypt"s inflation rises to 15.4 percent amid price hikes

Egypt says inflation jumped to 15.4 percent in September, a rise of more than two percentage points over the previous month......»»

Category: topSource: foxnewsOct 10th, 2018